The anti–B7-H3 ADC binds B7-H3 on tumor cells, is internalized, and releases a topoisomerase inhibitor payload that blocks DNA topoisomerase, halting DNA replication and triggering cell-cycle arrest and apoptosis of B7-H3–expressing cells.